Solid pseudopapillary neoplasms of the pancreas are dependent on the Wnt pathway.


Journal

Molecular oncology
ISSN: 1878-0261
Titre abrégé: Mol Oncol
Pays: United States
ID NLM: 101308230

Informations de publication

Date de publication:
08 2019
Historique:
received: 15 11 2018
revised: 07 02 2019
accepted: 08 04 2019
pubmed: 12 4 2019
medline: 6 5 2020
entrez: 12 4 2019
Statut: ppublish

Résumé

Solid pseudopapillary neoplasms (SPNs) are rare and relatively indolent tumors of the pancreas. While primary SPNs can be surgically resected, there are currently no therapies available for patients with advanced stage disease. Given that these tumors frequently carry CTNNB1 hotspot (recurrently mutated loci in a gene) mutations resulting in β-catenin nuclear accumulation, it has been speculated that the Wnt pathway may be a driver in this disease. Here, we present a comprehensive "multi-omics" study where the genome, transcriptome, and methylome of SPNs were analyzed. We found that SPNs are characterized by a low-complexity genome where somatic mutations in CTNNB1, present in 100% of the cases, are the only actionable genomic lesions. Compared to more common subtypes of pancreatic tumors (adenocarcinomas and pancreatic neuroendocrine tumors), SPNs show high expression levels of genes belonging to the Wnt pathway. Their methylome was consistent with an epithelial cell origin and a general upregulation of Wnt pathway genes. Clinical studies to evaluate the exquisite sensitivity of SPNs to inhibitors of the Wnt pathway are warranted.

Identifiants

pubmed: 30972907
doi: 10.1002/1878-0261.12490
pmc: PMC6670010
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1684-1692

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Informations de copyright

© 2019 The Authors. Published by FEBS Press and John Wiley & Sons Ltd.

Références

Nat Biotechnol. 2013 Mar;31(3):213-9
pubmed: 23396013
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Proc Natl Acad Sci U S A. 1999 Jan 5;96(1):139-44
pubmed: 9874785
Am J Pathol. 2002 Apr;160(4):1361-9
pubmed: 11943721
Proc Natl Acad Sci U S A. 2011 Dec 27;108(52):21188-93
pubmed: 22158988
Oncogene. 2017 Mar;36(11):1461-1473
pubmed: 27617575
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
Genome Res. 2012 Mar;22(3):568-76
pubmed: 22300766
Cell. 2013 Feb 14;152(4):714-26
pubmed: 23415222
Nucleic Acids Res. 2016 Sep 19;44(16):e131
pubmed: 27270079
Nature. 2017 Mar 2;543(7643):65-71
pubmed: 28199314
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Nat Methods. 2014 Oct;11(10):1033-6
pubmed: 25128977
Genome Biol. 2014 Oct 28;15(10):484
pubmed: 25348012
Nat Commun. 2018 Aug 30;9(1):3533
pubmed: 30166553
Oncotarget. 2016 Dec 20;7(51):84003-84016
pubmed: 27563825
Int J Mol Sci. 2017 Jan 03;18(1):
pubmed: 28054945
Nat Rev Mol Cell Biol. 2009 Apr;10(4):276-86
pubmed: 19305417
Biostatistics. 2007 Jan;8(1):118-27
pubmed: 16632515
Cell. 2018 Apr 5;173(2):371-385.e18
pubmed: 29625053
Nature. 2007 Jun 14;447(7146):799-816
pubmed: 17571346
Nat Biotechnol. 2012 May;30(5):413-21
pubmed: 22544022
Nat Biotechnol. 2016 Feb;34(2):155-63
pubmed: 26619011
Virchows Arch. 2016 Nov;469(5):523-532
pubmed: 27591765
Clin Cancer Res. 2017 Jul 15;23(14):3859-3870
pubmed: 28153863
J Pathol. 2019 Jan;247(1):123-134
pubmed: 30306561
Appl Clin Genet. 2015 Apr 16;8:95-107
pubmed: 25931827
J Natl Cancer Inst. 2014 Sep 10;106(9):
pubmed: 25214561
Int J Clin Exp Pathol. 2014 Sep 15;7(10):6889-97
pubmed: 25400772
Curr Opin Genet Dev. 1999 Feb;9(1):15-21
pubmed: 10072352
J Pathol. 2014 Mar;232(4):428-35
pubmed: 24293293
Commun Biol. 2018 Mar 22;1:20
pubmed: 30271907
J Proteome Res. 2015 Aug 7;14(8):3007-14
pubmed: 26148796
Gastroenterology. 2008 Oct;135(4):1288-300
pubmed: 18725219
J Natl Cancer Inst. 2018 Sep 1;110(9):1030-1034
pubmed: 29506079
Bioinformatics. 2012 Jul 15;28(14):1811-7
pubmed: 22581179
Semin Diagn Pathol. 2000 Feb;17(1):66-80
pubmed: 10721808
Cancer Res. 2001 Dec 1;61(23):8401-4
pubmed: 11731417
Mol Cell Biol. 2002 Feb;22(4):1172-83
pubmed: 11809808
Cell. 2017 Jun 1;169(6):985-999
pubmed: 28575679
Cancer Res. 2016 Dec 15;76(24):7118-7129
pubmed: 27913435

Auteurs

Pier Selenica (P)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Nitya Raj (N)

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Rahul Kumar (R)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

David N Brown (DN)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Oriol Arqués (O)

Department of Pathology, New York University Langone Medical Center and Medical School, NY, USA.

Diane Reidy (D)

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

David Klimstra (D)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Matija Snuderl (M)

Department of Pathology, New York University Langone Medical Center and Medical School, NY, USA.

Jonathan Serrano (J)

Department of Pathology, New York University Langone Medical Center and Medical School, NY, USA.

Héctor G Palmer (HG)

Stem Cells and Cancer Laboratory, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
CIBERONC, Madrid, Spain.

Britta Weigelt (B)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Jorge S Reis-Filho (JS)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Maurizio Scaltriti (M)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH